Position in RDY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,216,030
+$320,278 QoQ
Shares Held
87,800
+37.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRUDENTIAL FINANCIAL INC holds $155,923,449 across 33 Drug Manufacturers - Specialty & Generic names. RDY ranks #20 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
225,051 | $29,648,218 | |
| 2 | ZTS |
Zoetis Inc.
|
202,071 | $23,886,812 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
34,281 | $20,327,947 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
449,847 | $10,764,838 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
286,100 | $8,720,328 | |
| 6 | VTRS |
Viatris Inc
|
597,766 | $8,075,817 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
511,957 | $6,363,625 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
207,156 | $6,239,538 |
All Filings in RDY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,216,030 | 87,800 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $895,752 | 63,800 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,500,054 | 107,300 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,922,337 | 127,900 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,219,877 | 168,300 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,137,966 | 135,400 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,066,770 | 38,600 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,438,765 | 32,009 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,349,033 | 32,025 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,307,411 | 33,162 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,243,822 | 33,555 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,574,256 | 40,790 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,399,598 | 42,150 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,422,521 | 46,812 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,514,937 | 48,050 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $2,341,335 | 42,270 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,311,123 | 41,470 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,846,250 | 43,514 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,841,015 | 43,614 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,375,402 | 32,314 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,056,565 | 33,500 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $6,474,842 | 90,824 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $7,042,254 | 101,240 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,527,285 | 66,540 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $3,102,990 | 76,940 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||